GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » 3-Year ROIIC %

Enzymatica AB (XSAT:ENZY) 3-Year ROIIC % : 202.72% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Enzymatica AB 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Enzymatica AB's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 202.72%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Enzymatica AB's 3-Year ROIIC % or its related term are showing as below:

XSAT:ENZY's 3-Year ROIIC % is ranked better than
93.77% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 1.1 vs XSAT:ENZY: 202.72

Enzymatica AB 3-Year ROIIC % Historical Data

The historical data trend for Enzymatica AB's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB 3-Year ROIIC % Chart

Enzymatica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.19 139.41 -35.15 -302.80 202.72

Enzymatica AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 202.72 -

Competitive Comparison of Enzymatica AB's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's 3-Year ROIIC % falls into.



Enzymatica AB 3-Year ROIIC % Calculation

Enzymatica AB's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -48.0716124 (Dec. 2023) - -12.2091564 (Dec. 2020) )/( 112.201 (Dec. 2023) - 129.892 (Dec. 2020) )
=-35.862456/-17.691
=202.72%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Enzymatica AB  (XSAT:ENZY) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Enzymatica AB 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymatica AB (XSAT:ENZY) Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (XSAT:ENZY) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016